Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets
2007

Identifying Antihypertensive Targets in Hypertension Models

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Grayson T Hilton, Ohms Stephen J, Brackenbury Therese D, Meaney Kate R, Peng Kaiman, Pittelkow Yvonne E, Wilson Susan R, Sandow Shaun L, Hill Caryl E

Primary Institution: Australian National University

Hypothesis

The study aims to identify common therapeutic targets for hypertension through gene expression profiling in different models of the disease.

Conclusion

The study found that changes in caveolin-1 expression and G protein signaling regulators Rgs2 and Rgs5 may contribute to hypertension and serve as potential drug targets.

Supporting Evidence

  • Gene expression profiling identified over 800 genes with significant changes in hypertensive models.
  • Both hypertensive models showed increased caveolin-1 expression.
  • Rgs2 and Rgs5 were downregulated in both hypertensive models.

Takeaway

Researchers looked at blood vessels from rats with high blood pressure to find common problems that could help create new medicines to treat hypertension.

Methodology

Gene expression profiling was conducted on resistance arteries from normotensive and hypertensive rats, followed by statistical analysis of the data.

Potential Biases

Potential bias may arise from the use of animal models that may not fully replicate human hypertension.

Limitations

The study primarily focused on two models of hypertension, which may limit the generalizability of the findings.

Participant Demographics

The study used male WKY and SHR rats, aged 16 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-8-404

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication